Abstract

Since it has been demonstrated that hematoporphyrin derivative (HpD) is an effective photosensitizer in photoradiation therapy for treatment of a variety of solid malignant tumors in man, its photophysical, photochemical and biological behaviors have been widely investigated1. However, the mechanism that HpD selectively accumulates in malignant tumor cells is not yet well ungerstood.

© 1988 Optical Society of America

PDF Article
More Like This
Study of aggregation effects of hematoporphyrin derivatives by picosecond time- and wavelength-resolved spectroscopy

WEILI SHA, JUTAO CHEN, ZHENXING YU, and SONGHAO LIU
CFP5 Conference on Lasers and Electro-Optics (CLEO) 1990

Treatment of Intraocular Tumors with Hematoporphyrin-Derivative Photoradiation Therapy

Charles J. Gomer, A. Linn Murphree, Daniel R. Doiron, Nicholas J. Razum, and Stanley W. Fountain
FG2 International Quantum Electronics Conference (IQEC) 1984

Study of photodynamic therapy of malignant tumor and effect of various photosensitizers by laser microirradiation

HONG LIANG, ZHONGKANG LU, LANIAN WANG, RULANG JIANG, GUIYING SONG, YANHUA DENG, XIAOLAN OU, and ZHENGPING XU
THM59 Conference on Lasers and Electro-Optics (CLEO) 1988

References

You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an Optica member, or as an authorized user of your institution.

Contact your librarian or system administrator
or
Login to access Optica Member Subscription